Navigation Links
Novo Nordisk partners with international scientific community for Victoza(R) cardiovascular outcomes trial
Date:5/6/2010

your doctor right away if you have pain in your stomach area that is severe and will not go away, occurs with or without vomiting, or is felt going from your stomach area through to your back.  These may be symptoms of pancreatitis.

Before using Victoza®, tell your doctor about all the medications you take, especially sulfonylurea medicines or insulin, as taking them with Victoza® may affect how each medicine works.  

Also tell your doctor if you are allergic to any of the ingredients in Victoza®; have severe stomach problems such as slowed emptying of your stomach (gastroparesis) or problems with digesting food; have or have had kidney or liver problems; have any other medical conditions; are pregnant or plan to become pregnant.  Tell your doctor if you are breastfeeding or plan to breastfeed.  It is unknown if Victoza® will harm your unborn baby or if Victoza® passes into your breast milk.  

Your risk for getting hypoglycemia, or low blood sugar, is higher if you take Victoza® with another medicine that can cause low blood sugar, such as a sulfonylurea.  The dose of your sulfonylurea medicine may need to be lowered while taking Victoza®.

The most common side effects with Victoza® include headache, nausea, diarrhea, and resistance to liraglutide (antibody formation).  Nausea is most common when first starting Victoza®, but decreases over time in most people.  Immune system related reactions, including hives, were more common in people treated with Victoza® compared to people treated with other diabetes drugs in medical studies.  

For more information, ask your healthcare provider or pharmacist.

For full prescribing information, please go to Victoza.com or call 1-877-VICTOZA® (1
'/>"/>

SOURCE Novo Nordisk
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Novo Nordisk Awarded Department of Veterans Affairs National Insulin Contract
2. Novo Nordisks Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
3. Novo Nordisk is Changing Possibilities in Hemophilia
4. Novo Nordisk Wins Design Award for NovoTwist(TM) Needle
5. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
8. Medical City Hospital Partners With Dallas Fire-Rescue to Outfit First Mobile Units in Dallas County With Advanced EKG Technology
9. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
10. MCNC Partners With Sonic Foundry to Provide Classroom Technology to K-20 Community
11. Catalyst Pharmaceutical Partners Regains Compliance with NASDAQ Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... -- Compass Diversified Holdings (NYSE: CODI ) ("CODI," ... middle market businesses, announced today its consolidated operating results ... 2014. Fourth Quarter 2014 Highlights , ... or "Cash Flow") of $17.5 million for the fourth ... year 2014;  , Reported net income of $8.9 ...
(Date:3/2/2015)... , March 2, 2015  DURECT Corporation ... Epigenomic Regulator Program, and the successful completion of ... lead product candidate DUR-928.  DUR-928 is an endogenous, ... broad applicability in metabolic diseases such as nonalcoholic ... and in acute organ injuries such as acute ...
(Date:3/2/2015)... 2015 Click here for additional information on ... DPLO ), the nation,s largest independent specialty pharmacy, ... 31, 2014. All comparisons, unless otherwise noted, are to the ... Fourth Quarter 2014 Highlights include: , Revenue of ... dispensed of 208,000, an increase of 11% , Gross ...
Breaking Medicine Technology:Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 2Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 3Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 4Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 5Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 6Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 7Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 8Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 9Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 10Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 11Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 12Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 13Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 14Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 15DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 2Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 3Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 4Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 6Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 7Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 8Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 9Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 10Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 11Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 12Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 13Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 14Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 15Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 16Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 17Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 18
... Inc. (OTCQX: DATA), a technology and services company ... trials industry, today announced its participation in the ... will address significant milestones made throughout the pharmaceutical ... technologies are delivering. The EuroMeeting will be held ...
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) ... launch of its new formulation of Acetadote ® ... treat acetaminophen poisoning. The proprietary new formulation, which does ... other stabilization or chelating agents, is now stocked at ...
Cached Medicine Technology:DATATRAK to Attend DIA's 23rd Annual EuroMeeting 2New Acetadote® Formulation Now Available in the U.S. 2New Acetadote® Formulation Now Available in the U.S. 3New Acetadote® Formulation Now Available in the U.S. 4
(Date:3/2/2015)... New York (PRWEB) March 02, 2015 ... of women who were allegedly harmed by the long-acting ... and federal courts around the U.S., according to Bernstein ... District Court, Eastern District of California on February 24th, ... case pending in that jurisdiction may pursue her lawsuit, ...
(Date:3/2/2015)... Cutler Integrative Medicine a leader in bringing innovative naturopathic ... to bring about self-renewal. A 30 day detox is ... cleaning house. According to Dr. Cutler, expert in ... environmental toxins like heavy metals, people’s food now becoming ... levels, we all have a level of toxic burden. ...
(Date:3/2/2015)... Monroeville, PA (PRWEB) March 02, 2015 ... part of the Allegheny Health Network, are ... with new software called Visual Info Zonal Reminder (VIZR), ... , Introduced in 2013, Google Glass is a wearable ... in a smartphone-like hands-free format. Wearers communicate with the ...
(Date:3/2/2015)... 02, 2015 GBCHealth, a prominent ... private sector activities and investments in global health ... four new members to serve on the organization’s ... Farmer, Chief Strategist and Co-founder of Partners In ... Dr. Huma Abbasi, General Manager of Global Health ...
(Date:3/2/2015)... UK (PRWEB) March 02, 2015 Market ... research reports worked out by Global Industry Analysts Inc ... Therapy Equipment: Market Research Report . Through 2018, the ... a 6.04% CAGR. The detailed research report suggests a ... for radiation therapy equipment as well as covers the ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Court’s Decision to Allow Certain Claims to Stand in Mirena Injury Case 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Court’s Decision to Allow Certain Claims to Stand in Mirena Injury Case 3Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Court’s Decision to Allow Certain Claims to Stand in Mirena Injury Case 4Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3
... of this year, colonoscopy screening will have prevented bowel ... introduced in Germany. This is the result obtained by ... Heidelberg and his co-authors in their interim assessment conducted ... German cancer screening program. The authors present their projection ...
... Many aspects of the German Genetic Diagnostics Act (Gendiagnostikgesetz) ... impossible to implement in clinical practice, or even detrimental ... newborn screening. The Act, which came into force in ... was the conclusion reached by the Academy Workgroup "Predictive ...
... WEDNESDAY, Nov. 10 (HealthDay News) -- U.S. college students ... move through their academic career, a new study has ... less active and heavier compared to the start of ... study author Jeanne Johnston, assistant professor in Indiana University,s ...
... HealthDay Reporter , WEDNESDAY, Nov. 10 (HealthDay News) -- ... increase the risk of cancer and may even decrease users, ... finds. Studies have shown that the short-term use of ... has little effect on the risk of developing cancer, but ...
... -- Women who were victims of childhood abuse may be ... suggest. Researchers surveyed 67,853 U.S. nurses and found that ... abuse before age 18. Moderate and severe physical and sexual ... increased risk of type 2 diabetes in adulthood. "Much, ...
... Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the ... shown that Docosahexaenoic acid (DHA), a component of fish ... tissue and promote recovery in an experimental model of acute ... five hours. These findings not only target a new stroke ...
Cached Medicine News:Health News:Academies of science call for amendments to impracticable Genetic Diagnostics Act 2Health News:Academies of science call for amendments to impracticable Genetic Diagnostics Act 3Health News:Activity Level Seems to Decline Throughout College Years 2Health News:Long-Term Statin Use Won't Raise Cancer Risk: Study 2Health News:Childhood Abuse Linked to Diabetes Risk in Adult Women 2Health News:Louisiana State University Health Sciences Center research shows fish oil component given up to 5 hours after stroke limits brain damage 2Health News:Louisiana State University Health Sciences Center research shows fish oil component given up to 5 hours after stroke limits brain damage 3
... X-22 Series is up to 10 inches/ 25 cm ... 11 rotors, the Allegra X-22 Series is the space-saving ... Only 18 inches / 46 cm wide • 11 ... 3 different ways to Spin 1.5 mL & ...
... purpose centrifuges offer high-volume versatility along with ... making them ideal for a wide variety ... Four- or six-place sealed swinging bucket ... rotors offered , Lare capacity (4 x ...
... high performance centrifuge designed to accommodate over ... is refrigerated for heat labile samples. Incorporating ... refrigerated capability with automatic quick cooling from ... 7 min, no maintenance brushless motor, low ...
Inquire...
Medicine Products: